Xiaohui Wei

651 total citations
13 papers, 513 citations indexed

About

Xiaohui Wei is a scholar working on Oncology, Pharmacology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Xiaohui Wei has authored 13 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Pharmacology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Xiaohui Wei's work include Antibiotics Pharmacokinetics and Efficacy (3 papers), Acute Myeloid Leukemia Research (2 papers) and Antibiotic Resistance in Bacteria (2 papers). Xiaohui Wei is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (3 papers), Acute Myeloid Leukemia Research (2 papers) and Antibiotic Resistance in Bacteria (2 papers). Xiaohui Wei collaborates with scholars based in United States, China and Hong Kong. Xiaohui Wei's co-authors include Jacqueline McBride, Kenneth Kalunian, Romeo Maciuca, Joan T. Merrill, Michael J. Townsend, William P. Kennedy, John C. Davis, Dimitry M. Danilenko, Diana Luca and Richard N. Fedorak and has published in prestigious journals such as Blood, Clinical Infectious Diseases and Gut.

In The Last Decade

Xiaohui Wei

13 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaohui Wei United States	8	244	242	110	102	91	13	513
Steven Jungerwirth United States	7	92 0.4×	264 1.1×	15 0.1×	37 0.4×	158 1.7×	8	483
Pintip Ngamjanyaporn Thailand	13	235 1.0×	299 1.2×	56 0.5×	38 0.4×	48 0.5×	32	509
Chun Lai Too Malaysia	11	120 0.5×	240 1.0×	80 0.7×	63 0.6×	29 0.3×	22	453
Antti Kuuliala Finland	15	142 0.6×	258 1.1×	37 0.3×	29 0.3×	99 1.1×	36	581
Ehtisham Akhter United States	9	325 1.3×	296 1.2×	85 0.8×	44 0.4×	35 0.4×	11	527
Wendy Komocsar United States	11	163 0.7×	102 0.4×	54 0.5×	49 0.5×	37 0.4×	28	338
Terasu Honma Japan	15	105 0.4×	60 0.2×	14 0.1×	112 1.1×	95 1.0×	75	652
Ottavia Magnani Italy	8	211 0.9×	97 0.4×	30 0.3×	34 0.3×	48 0.5×	10	418
S. John United Kingdom	8	159 0.7×	118 0.5×	26 0.2×	57 0.6×	50 0.5×	15	350
Tsuneo Nishiura Japan	10	44 0.2×	108 0.4×	54 0.5×	20 0.2×	62 0.7×	38	608

Countries citing papers authored by Xiaohui Wei

Since Specialization

Citations

This map shows the geographic impact of Xiaohui Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohui Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohui Wei more than expected).

Fields of papers citing papers by Xiaohui Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohui Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohui Wei. The network helps show where Xiaohui Wei may publish in the future.

Co-authorship network of co-authors of Xiaohui Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohui Wei. A scholar is included among the top collaborators of Xiaohui Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohui Wei. Xiaohui Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Qi, Xiaojing, Daniel B. Rubin, Simone M. Shurland, et al.. (2024). Flexible Development Programs for Antibacterial Drugs to Address Unmet Medical Needs. Emerging infectious diseases. 30(11). 2227–2230. 1 indexed citations

Chen, Yongfeng, et al.. (2023). Diabetes knowledge and training needs among non-endocrinology nurses. Heliyon. 9(5). e15985–e15985. 3 indexed citations

Sun, Zhuo, Xiaohui Wei, Jian’an Bai, et al.. (2022). The effects of curcumin on anthropometric and cardiometabolic parameters of patients with metabolic related diseases: a systematic review and dose-effect meta-analysis of randomized controlled trials. Critical Reviews in Food Science and Nutrition. 63(28). 9282–9298. 15 indexed citations

Zhu, Zhenni, Chunyan Luo, Xiaohui Wei, et al.. (2021). Effects of School-Based Interventions on Reducing Sugar-Sweetened Beverage Consumption among Chinese Children and Adolescents. Nutrients. 13(6). 1862–1862. 7 indexed citations

Zhu, Zhenni, et al.. (2021). Dietary Sodium Intake Is Positively Associated with Sugar-Sweetened Beverage Consumption in Chinese Children and Adolescents. Nutrients. 13(11). 3949–3949. 7 indexed citations

Zhuang, Luning, Yichao Yu, Xiaohui Wei, et al.. (2020). Evaluation of Hemodialysis Effect on Pharmacokinetics of Meropenem/Vaborbactam in End‐Stage Renal Disease Patients Using Modeling and Simulation. The Journal of Clinical Pharmacology. 60(8). 1011–1021. 7 indexed citations

Weinstein, Edward A., Daniel B. Rubin, Xiaohui Wei, et al.. (2020). US Food and Drug Administration (FDA): Benefit-Risk Considerations for Cefiderocol (Fetroja®). Clinical Infectious Diseases. 72(12). e1103–e1111. 38 indexed citations

Liu, Shuguang, Xiaohui Wei, Bin Yan, et al.. (2018). Non-small cell lung cancer leptomeningeal metastases treated with intrathecal therapy plus osimertinib and temozolomide and whole-brain radiation therapy: a case report. OncoTargets and Therapy. Volume 11. 4733–4738. 12 indexed citations

Kalunian, Kenneth, Joan T. Merrill, Romeo Maciuca, et al.. (2015). A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE). Annals of the Rheumatic Diseases. 75(1). 196–202. 275 indexed citations

10.

Wei, Xiaohui, Diana Luca, Yehong Wang, et al.. (2014). Etrolizumab Population Pharmacokinetics (Pop PK) and Covariate Analysis in Patients With Moderately to Severely Active Ulcerative Colitis (UC). The American Journal of Gastroenterology. 109. S496–S496. 3 indexed citations

11.

Rutgeerts, Paul, Richard N. Fedorak, Daan W. Hommes, et al.. (2012). A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis. Gut. 62(8). 1122–1130. 111 indexed citations

12.

Klisovic, Rebecca B., William Blum, Xiaohui Wei, et al.. (2008). Phase I Study of GTI-2040, an Antisense to Ribonucleotide Reductase, in Combination with High-Dose Cytarabine in Patients with Acute Myeloid Leukemia. Clinical Cancer Research. 14(12). 3889–3895. 30 indexed citations

13.

Klisovic, Rebecca B., William Blum, Xiaohui Wei, et al.. (2005). A Phase I Study of GTI-2040, an Antisense to Ribonucleotide Reductase (RNR) in Combination with High-Dose Cytarabine (HiDAC) in Relapsed or Refractory Acute Myeloid Leukemia (AML): Pharmacokinetics (PK), Pharmacodynamic (PD) and Clinical Results.. Blood. 106(11). 2790–2790. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact